Furthermore, edaravone dexborneol exerted neuroprotective effect by inhibiting NF-κB/NLRP3/GSDMD signaling pathway and inflammatory factors (IL-1β and IL-18) in experimental ischemic stroke [32]. Here, GSDMD is linked to ischemic stroke.